Staging and survival of rectal cancer in Vila Nova de Gaia, Portugal

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 2, 2010, Pages 151-156

  Abreu, Miguel Henriques ^a   Matos, Eduarda ^a,c   Castro Pocas, Fernando ^a,b   Rocha, Rosa ^c   Pinto, Jorge ^c   Lopes, Carlos ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^c Oncological Registry of Gaia   (Portugal)

Author keywords

Incidence; Rectal cancer; Registry; Stage; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PORTUGAL; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; TOPOGRAPHY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PORTUGAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 75749110251     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283307c5c     Document Type: Article

References (49)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Snigal C, Them MPH. Cancer statistics, 2006. CA Cancer J Clin 2006; 56:106.
2. Epidemiology Division. The Risk of Death in Portugal. Lisbon: Health General Diection; 2001. Report No. ISSN 0873-089 X.
3. Pereira L. In: http//www. portoxxi. com. [Accessed in 28/3/2008]
4. Burt RW, DiSario JA, Cannon-Albright L. Genetics of colon cancer: impact of inheritance on colon cancer risk. Annu Rev Med 1995; 46:371.
5. Lynch HT, Smyrk TC, Watson P, Lauspa SJ, Lynch JF, Lynch PM, Cavalieri RJ, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993; 104:1535.
6. Ponz de Leon M, Sassatelli R, Benatti P, Roncucci L. Identification of hereditary nonpolyposis colorectal cancer in the general population: the 6-year experience of a population-based registry. Cancer 1993; 71:3493.
7. Consorti F, Lorenzotti A, Midiri G, Di Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol 2000; 73:70.
8. Thoeni RF. Colorectal cancer. Radiologic staging. Radiol Clin North Am 1997; 35:457.
9. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Vol. VIII. Lyon: IARC Scientific Publications, No. 155; 2002.
10. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin D, Whelan S. International classification of diseases for oncology. 3rd ed. Geneva: WHO; 1990.
11. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M, editors. AJCC (American Joint Committee on Cancer) cancer staging manual. 6th ed. New York: Springer-Verlag; 2002. p. 114.
12. Ponz de Leon M, Rossi G, Di Gregorio C, de Gaetani C, Rossi F, Ponti G, et al. Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. Intern Emerg Med 2007; 2:269-279.
13. Ponz de Leon M, Benatti P, Di Gregorio C, Fante R, Rossi G, Losi L, et al. Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a specialized cancer registry. Dig Liver Dis 2000; 32:312-317.
14. Ponz de Leon M, Marino M, Benatti P, Rossi G, Mengatti M, Pedroni M, et al. Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer register. Ann Oncol 2004; 15:940-946.
15. Larsson SC, Bergkvist L, Wolk A. Magnesium intake in relation to risk of colorectal cancer in women. JAMA 2005; 293:86.
16. Grodstein F, Martinez ME, Platz EA, Giovannucci E, Colditz GA, Kartzky M, et al. Postmenopausal hormone use and the risk for colorectal cancer and adenoma. Ann Intern Med 1998; 128:705.
17. Calle EE, Miraclemcmahill HL, Thun MJ, Heath CW. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 1995; 87:517.
18. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999; 106:574.
19. Slattery ML, Potter JD, Curtin K, Edward S, Ma KN, Anderson K, et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 2001; 61:126.
20. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004; 350:991.
21. Amado J. Epidemiology and cancer registries: the contribution of a population- based oncological registry, 1994. PhD. Thesis, ICBAS, University of Oporto.
22. Newland RC, Dent OF, Lyttle MN, Chapuis PH. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994; 73:2076.
23. Secco GB, Fardelli R, Campora E, Lapertosa G. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology 1994; 51:30.
24. Halvorsen TB, Seim E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol 1989; 42:162.
25. Ofner D, Riedmann B, Maier H, Hittmair A. Standardized staining and analysis of argyrophilic nucleolar organizer region associated proteins (AgNORs) in radicallyresected colorectal adenocarcinoma - correlation with tumour stage and long-term survival. J Pathol 1995; 175:441.
26. Michelassi F, Ayala JJ, Balestracci T, Goldberg R. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma. Ann Surg 1991; 214:11.
27. Harrison JC, Dean PJ, el-Zeky F, Vander Zwaag R. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol 1994; 25:498.
28. Wolmark N, Wieand HS, Rockette HE, Fisher B. The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials. Ann Surg 1983; 198:743.
29. Carraro PG, Segala M, Cesana BM, Tiberio G. Obstructing colonic cancer: failure and survival patterns over a ten-year follow-up after one-stage curative surgery. Dis Colon Rectum 2001; 44:243.
30. Crucitti F, Sofo L, Doglietto GB, Bellantone R, Ratto C, Bossola M, Crucitti A. Prognostic factors in colorectal cancer: current status and new trends. J Surg Oncol Suppl 1991; 2:76.
31. Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, Colquhoun K. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985; 72:698.
32. Halvorsen TB, Johannesen E. DNA ploidy, tumor site, and prognosis in colorectal cancer. Scand J Gastroenterol 1990; 25:141.
33. Jessup JM, Stewart AK, Menck HR. The National Cancer Data Base report on patterns of care for adenocarcinoma of the rectum, 1985-1995. Cancer 1998; 83:2408.
34. Gunderson L, Sargent D, Tepper J. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer. J Clin Oncol 2004; 22: 1785-1796.
35. Harling H, Bülow S, Kronborg O, Moller LN, Jorgensen T. Survival of rectal cancer patients in Denmark during 1994-1999. Clorectal Dis 2004; 6:153-157. (Pubitemid 38660633)
36. Reerink O, Mulder N, Botke G, Sluiter WJ, Szabó BG, Plukker JT. Treatment of locally recurrent rectal cancer, results and prognostic factors. Eur J Surg Oncol 2004; 30:954-958.
37. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, et al. Stage at diagnosis is a key explanation of differences in breast câncer survival across Europe. Int J Cancer 2003; 106:416-422.
38. Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000; 47:533-538.
39. Sant M, Allemani C, Berrino F, Oleman MP, Aareleid T, Chaplain G, et al. Breast carcinoma survival in Europe and the United States. Cancer 2004; 100:715-722.
40. Berrino F, De Angelis R, Sant M, Rosso M, Bielska-Lasota M, Coebergh JW, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-1999: results of the EUROCARE-4 study. Lancet Oncol 2007; 8:773-783.
41. Jemal A, Siegel R, Ward E, Murray Y, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43.
42. Speights VO, Johnson MW, Stoltenberg PH, Rappaport ES, Helbert B, Riggs M. Colorectal cancer: current trends in initial clinical manifestations. South Med J 1991; 84:575.
43. Beahrs OH, Sanfelippo PM. Factors in prognosis of colon and rectal cancer. Cancer 1971; 28:213.
44. Copeland EM, Miller LD, Jones RS. Prognostic factors in carcinoma of the colon and rectum. Am J Surg 1968; 116:875.
45. Greene FL, Stewart AK, Norton HJ. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis. J Clin Oncol 2004; 22:1778.
46. Zarychanski R, Chen Y, Bernstein CN, Hebert PC. Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour. CMAJ 2007; 177:593.
47. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003; 124:544-560.
48. Wu X, Chen VW, Martin J, Roffers S, Groves FD, Correa CN, et al. Subsitespecific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995-1999. Cancer Epidemiol Biomarkers Prev 2004; 13:1215.
49. Saunders BP, Fukumoto M, Halligan S, Jobling C, Moussa ME, Bartram CI, Williams CB. Why is colonoscopy more difficult in women? Gastrointest Endosc 1996; 43:124-126.